Join

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

  • ParaZero Technologies Ltd. logo
    PR··Industrials·
    ParaZero Expands U.S. Footprint with Order from a New Customer, an American Defense Manufacturer

    Order includes Net Pods and integration support to add net interception capabilities to a drone interceptor platform designed for critical infrastructure and strategic site protection KFAR SABA, Israel, Oct. 08, 2026 (GLOBE NEWSWIRE) --   ParaZero Technologies Ltd. (NASDAQ:PRZO) ("ParaZero" or the "Company"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced receipt of an initial order from a new U.S.-based defense manufacturer for DefendAir Net Pods and related integration support. The customer develops drone detection and interception technologies and holds contracts to protect critical

  • Spring Valley Acquisition Corp. III logo
    PR··Finance·
    General Fusion, UKAEA Announce Magnetized Target Fusion Milestone

    VANCOUVER, British Columbia and OXFORD, England, Oct. 08, 2026 (GLOBE NEWSWIRE) -- General Fusion Group Ltd. (NASDAQ:GFUZ) ("General Fusion" or the "Company"), a leading fusion company, has achieved a historic compressional plasma heating result with its large-scale Lawson Machine 26 ("LM26") demonstration. Using Magnetized Target Fusion ("MTF"), the Company reached electron temperatures exceeding 12 million degrees Celsius – more than 1 keV. The results were co-published by the UK Atomic Energy Authority ("UKAEA"), the UK’s national fusion laboratory, and measured using gold-standard Thomson scattering methods. Only a few fusion companies have surpassed the industry-recognized milestone

  • Viatris Inc. logo
    Pacira BioSciences Inc. logo
    PR··Health Care·
    Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

    Adds Two Marketed, Patent-Protected, High-Margin Medicines in the U.S., EXPAREL® and ZILRETTA®, and Expects to Expand the Products' Reach Across Selected Markets Within Its International Infrastructure Expands U.S. Innovative Medicines Commercial, Market Access, Medical Affairs and Global R&D CapabilitiesExpected to Be Synergistic With Viatris' Fast-Acting Meloxicam OpportunityDeal Anticipated to Close By the End of 2026 and to Be Immediately Accretive to Viatris' Financial Guidance Metrics Transaction Consistent With Viatris' Disciplined and Balanced Capital Allocation Strategy and Preserves Financial Flexibility PITTSBURGH and BRISBANE, Calif. , Oct. 8, 2026 /PRNewswire/ -- Viatris Inc. (N

  • Mynd.ai Inc. logo
    PR··Real Estate·
    Mynd.ai Announces CEO and CFO Transition

    ATLANTA, Oct. 8, 2026 /PRNewswire/ -- Mynd.ai, Inc. ("Mynd" or the "Company") (NYSE:MYND), a global leader in interactive hardware and software solutions for education and enterprise, today announced that Arthur Giterman, Chief Executive Officer and Chief Financial Officer, will be stepping down from his roles as CEO and CFO effective October 11, 2026. Mr. Giterman will also resign as a member of the Company's Board of Directors effective October 11, 2026.The Board of Directors has appointed Bin Shen as Chief Executive Officer and Interim Chief Financial Officer, effective October 12, 2026. The Company intends to appoint a permanent Chief Financial Officer upon the completion of a comprehens

  • VenHub Global Inc. logo
    PR··Technology·
    VenHub to Expand Smart Store Deployments Into Multifamily Residential Market; First VenHub Autonomous Retail Store Will Be at Penn Lofts in Bend, Oregon

    LAS VEGAS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- VenHub Global, Inc. (NASDAQ:VHUB) ("VenHub" or the "Company"), a leader in fully autonomous Smart Store technology, today announced plans for the first deployment of its Smart Store autonomous retail platform at Penn Lofts, a new 59-unit multifamily development in Bend, Oregon.The deployment represents an important expansion of the VenHub Smart Store platform into the multifamily residential market, where the Company is seeing growing demand from developers and property owners seeking new ways to enhance the resident experience and differentiate their communities. By bringing convenient access to everyday products and essentials directly to wher

  • PulteGroup Inc. logo
    PR··Consumer Discretionary·
    Explore by Del Webb Expands into Utah with New Community Near Park City

    Explore by Del Webb Jordanelle Ridge brings the brand’s signature style of wellness and elevated amenities to one of Utah’s most sought-after destinations Mountains, luxury design and wellness with a view. PulteGroup (NYSE:PHM), the nation’s third-largest home builder, is bringing Explore by Del Webb to Utah’s Jordanelle Ridge, marking the latest expansion of its newest brand. Launched in 2025, Explore draws on Del Webb’s 65 years of experience creating resort-style communities. Offering a fresh perspective, Explore communities are centered on thoughtful designs, elevated amenities and experiences that make it easy to live well, stay active and connect. Just minutes from Park City and D

  • GSK plc logo
    PR··Health Care·
    Viola Davis partners with GSK to educate adults 50 and older about their shingles risk

    For the first time, Viola Davis shares her experience with shinglesViola encourages adults 50 years and older to prioritize their health and have candid conversations about increased risks that come with agingThe partnership is part of GSK's new national "Shingles, actually" disease education campaignPHILADELPHIA, Oct. 8, 2026 /PRNewswire/ -- GSK plc (LSE/NYSE:GSK) today announced a partnership with award-winning actress, producer and philanthropist Viola Davis to launch "Shingles, actually", a new educational campaign designed to spark conversations about the realities of aging, including the risk of shingles for adults 50 years and older. As part of the "Shingles, actually" campaign, Viola

  • Clearmind Medicine Inc. logo
    PR··Health Care·
    Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder

    Published patent application covers 3-MMC-based treatment of dyskinesia, including in combination with Palmitoylethanolamide (PEA) Vancouver, Canada, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND) (the "Company"), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment  of neuropsychiatric, metabolic, and addiction disorders including Alcohol Use Disorder ("AUD"), today announced the publication of a patent application in Japan covering novel compositions and methods for treating dyskinesia, a neurological movement disorder characterized by involuntary movements. The published patent applic

  • Diamondrock Hospitality Company logo
    PR··Real Estate·
    DIAMONDROCK HOSPITALITY COMPANY ACQUIRES THE BELLMOOR INN & SPA

    BETHESDA, Md., Oct. 8, 2026 /PRNewswire/ -- DiamondRock Hospitality Company (the "Company") announced today its acquisition of the fee simple interest in The Bellmoor Inn & Spa (the "Hotel" or "The Bellmoor"), a 79-room luxury resort in Rehoboth Beach, Delaware, for total consideration of $31.0 million, or approximately $392,000 per key. The acquisition was funded with cash on hand and represents an attractive opportunity to acquire an independent resort in a supply-constrained market with strong in-place cash flow and meaningful operational upside.Based on the Hotel's trailing twelve-month results ended August 2026, the acquisition price represents a 10.4x Hotel EBITDA multiple and an 8.6%

  • Crocs Inc. logo
    PR··Consumer Discretionary·
    Crocs, Inc. Announces Conference Call to Review Third Quarter 2026 Earnings Results

    BROOMFIELD, Colo., Oct. 8, 2026 /PRNewswire/ -- Crocs, Inc. (NASDAQ:CROX) announced today that on Thursday, October 29, 2026, at 8:30 am ET, it will host a conference call to discuss the results of its third quarter ended September 30, 2026.To receive conference call details, please register at the Investor Relations section of the Crocs website, investors.crocs.com. The webcast will also be available live and on replay through October 29, 2027 at this site.About Crocs, Inc.: Crocs, Inc. (NASDAQ:CROX), headquartered in Broomfield, Colorado, is a world leader in innovative casual footwear for all, combining comfort and style with a value that consumers know and love. The Company's brands incl

  • Bank Of Montreal logo
    PR··Finance·
    BMO Launches New Latin America Index ETF and Two New ETF Series

    New ETF and ETF Series broaden investor choice across Latin American equities and Canadian and emerging-market fixed incomeTORONTO, Oct. 8, 2026 /CNW/ -- BMO Asset Management Inc., the manager of the BMO ETFs, today announced the launch of BMO MSCI Latin America GDP Weighted Index ETF, offering CAD Units (TSX:ZLAT). In addition, BMO Investments Inc., the manager of the BMO Mutual Funds, today announced the launch of ETF Series units for BMO Core Bond Fund (TSX:ZCRB) and BMO Emerging Markets Bond Fund (TSX:ZEMB).BMO MSCI Latin America GDP Weighted Index ETF has closed its initial offering of CAD Units, and they will be listed and begin trading on the Toronto Stock Exchange today.BMO Core Bond

  • Galiano Gold Inc. logo
    PR··Industrials·
    Galiano Gold Secures Long-Term Extension of Key Mining Leases at the Asanko Gold Mine

    Vancouver, British Columbia--(Newsfile Corp. - October 8, 2026) - Galiano Gold Inc. (TSX:GAU) (NYSE:GAU) ("Galiano" or the "Company") is pleased to announce that it has secured the extension of the Abirem and Miradani Mining Leases at the Asanko Gold Mine ("AGM") in Ghana. The Abirem Mining Lease has been extended for 15 years through 2041, while the Miradani Mining Lease has been extended for 17 years through 2043.The Abirem and Miradani Mining Leases host the Nkran, Adubiaso and Miradani North deposits, including the AGM's 5.8 million tonnes per annum processing facility, associated infrastructure and Nkran Cut 3, a key component of the AGM's long-term mine plan."We are very pleased with t

  • Mallinckrodt plc logo
    PR··Health Care·
    Keenova Announces New Presentations at the Sexual Medicine Society of North America Annual Meeting

    DUBLIN, Oct. 8, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that it will share data and insights related to men's health during three speaker presentations at the Sexual Medicine Society of North America annual meeting, taking place October 8-11, 2026.Two presentations will highlight clinical studies and real-world treatment experience supporting the use of XIAFLEX® (collagenase clostridium histolyticum) as a nonsurgical treatment option for men with Peyronie's disease, including those with ventral curvature.The third presentation will feature Keenova's Men's Sexual Health Screener, a clinician-patient communication resource designed to help facilitate more efficient assess

  • Snap-On Incorporated logo
    PR··Consumer Discretionary·
    Snap-on Incorporated to Webcast 2026 Third Quarter Results Conference Call

    Snap-on Incorporated (NYSE:SNA) will release 2026 third quarter results prior to the market open on Thursday, October 22, 2026. A conference call to discuss the results will be held at 10:00 a.m. ET on that day. The conference call audio and accompanying slides will be webcast live via the Internet.To access the call, visit https://www.snapon.com/EN/Investors/Investor-Events and click on the link to the webcast. The quarterly release and slides that will accompany the call can be accessed under the Downloads tab in the webcast viewer, as well as on the Snap-on website, www.snapon.com. An archived replay will be available on the website for at least one week following the call.About Snap-onSn

  • Agenus Inc. logo
    PR··Health Care·
    Armenia Grants First Marketing Authorizations for Agenus’ BOT+BAL in Previously Treated MSS Metastatic Colorectal Cancer

    Botvymo® (botensilimab) and Evamplix® (balstilimab) receive separate approvals for use in combination Armenia is the first country to approve marketing authorization of BOT+BAL, following a rigorous review of quality, nonclinical, clinical and pharmacovigilance data Approvals supported by clinical evidence published in peer-reviewed journals and presented at major oncology congresses, including two-year Phase 1b survival findings and randomized Phase 2 data in MSS metastatic colorectal cancer without active liver metastases Agenus will evaluate the potential for approvals in other Eurasian Economic Union countries that support this regulatory path Agenus Inc. (NASDAQ:AGEN), a l

  • SolarEdge Technologies Inc. logo
    PR··Technology·
    SolarEdge Appoints Gokul Krishnan as SVP and General Manager, North America

    Veteran solar and semiconductor executive provides operating experience to lead North America residential and commercial growth SolarEdge Technologies, Inc. (NASDAQ:SEDG), a global leader in smart energy technology, today announced the appointment of Gokul Krishnan as Senior Vice President and General Manager, North America. Krishnan brings more than two decades of senior leadership experience across semiconductors, solar, power electronics, energy storage, and grid services. The appointment comes as North American energy markets continue to converge on SolarEdge's core strengths in power electronics. AI infrastructure. AI factory and data center buildout is straining grid capacity.

  • Hyperfine Inc. logo
    PR··Health Care·
    Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026

    Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the third quarter 2026 on Monday, November 9, 2026. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live audio webcast and an archive of the recording will be available through the Investors page of Hyperfine, Inc.’s corporate website at https://investors.hyperfine.io/. Participants are encouraged to register more than 15 minutes before the start of the call. For more informat

  • The Real Brokerage Inc. logo
    PR··Finance·
    Joy and Robert Aumann Bring LUXURYSOCALREALTY to Real

    Nationally recognized San Diego luxury team has amassed more than $750 million in career sales volume, including a record-setting $47 million La Jolla sale The Real Brokerage Inc., a leading technology-enabled real estate platform redefining the industry through innovation and agent culture, today announced that Joy and Robert Aumann, founders of LUXURYSOCALREALTY, have joined the company. The move brings the 10-member San Diego team to Real Luxury and strengthens the company’s presence across some of Southern California’s most sought-after coastal communities. Based in San Diego, LUXURYSOCALREALTY represents buyers and sellers of high-value coastal properties, oceanfront estates and lu

  • Hyperfine Inc. logo
    PR··Health Care·
    Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million

    Preliminary Revenue Represents 53% Sequential Quarterly Growth; Company Reaffirms 2026 Financial Guidance and Expects Quarter-End Cash and Cash Equivalents of Approximately $37.9 Million Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited revenue, net cash burn, and cash and cash equivalents for the third quarter ended September 30, 2026. "Our preliminary third-quarter results demonstrate that execution of our commercial strategy is driving meaningful growth. Momentum was strong across our three commerci

  • TG Therapeutics Inc. logo
    PR··Health Care·
    TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026

    Late-breaking oral presentation will highlight initial clinical results evaluating azer-cel, an allogeneic "off-the-shelf" CD19-directed CAR T-cell therapy, in patients with progressive multiple sclerosis Additional presentations include Phase 3 ENHANCE data supporting the investigational BRIUMVI single dose initiation schedule, full Phase I subcutaneous BRIUMVI results, seven-year clinical outcomes and growing real-world evidence TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the schedule of upcoming presentations at the 10th Joint ACTRIMS-ECTRIMS Meeting, also referred to as MSToronto2026, being held October 21-23, 2026, in Toronto, Canada. The presentations include a late-break